It is informed that Nomination & Remuneration Committee in its Meeting held today i.e. May 11, 2026 has made a grant of 10,000 Options under GHL LTIP 2024.
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Global Health Ltd (Medanta) has announced that its Nomination and Remuneration Committee approved the grant of 10,000 stock options to one employee under the GHL Employees Stock Option Scheme 2024. Each option converts into one equity share of Rs. 2 each at an exercise price of Rs. 960 per option. The vesting period extends up to 5 years from the grant date, with a maximum exercise period of 3 years from the date of vesting of the last instalment. This is a routine disclosure under SEBI LODR regulations and forms part of the company's long-term incentive plan designed to attract, retain, and motivate key talent.
This is a routine corporate governance matter with minimal direct impact on shareholders. The dilution from 10,000 shares is negligible, and the announcement primarily provides transparency on employee compensation structures.